Señales en vivo de QSAM | Maximiza tus Ganancias con Getagraph.com

Live Chart Being Loaded With Signals

Commentary (2 may 2024 @ 15:59):

Stats
Volumen de hoy	133 563
Volumen promedio	11 467.00
Capitalización de mercado	73.79B
EPS	$0 ( 2024-03-12 )
Próxima fecha de ganancias	( $0 ) 2024-05-13
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	-9 822.49
ATR14	$0.0340 (0.41%)

Insider Trading

Date	Person	Action	Amount	type
2024-05-02	Piazza C Richard	Sell	188	Common Stock
2024-05-02	Baum Douglas R	Sell	188	Common Stock
2024-05-02	Link Jr. Charles J	Sell	41	Common Stock
2024-05-02	Nelson Christopher M.	Sell	91	Common Stock
2024-05-02	Sax Adriann	Sell	5	Common Stock

INSIDER POWER
67.23
Last 86 transactions
Buy: 23 187 033 \| Sell: 6 677 111

QSAM Biosciences, Inc. Correlación

10 Correlaciones Más Positivas

10 Correlaciones Más Negativas

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

QSAM Biosciences, Inc. Finanzas

Annual	2023
Ingresos:	$0
Beneficio Bruto:	$0 (0.00 %)
EPS:	$-1.440

FY	2023
Ingresos:	$0
Beneficio Bruto:	$0 (0.00 %)
EPS:	$-1.440

FY	2022
Ingresos:	$0
Beneficio Bruto:	$0 (0.00 %)
EPS:	$-3.45

FY	2021
Ingresos:	$0.00
Beneficio Bruto:	$0.00 (0.00 %)
EPS:	$-86.75

Financial Reports:

No articles found.

QSAM Biosciences, Inc.

QSAM Biosciences, Inc. engages in developing various nuclear medicines for the treatment of cancer and related diseases. The company is involved in the development of CycloSam (Samaium-153 DOTMP), a clinical-stage bone targeting radiopharmaceutical. It has a license agreement with IGL Pharma, Inc. The company was formerly known as Q2Earth, Inc. and changed its name to QSAM Biosciences, Inc. in September 2020. QSAM Biosciences, Inc. was incorporated in 2004 and is headquartered in Austin, Texas.